查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1720881

2025年呼吸道融合細胞病毒（RSV）診斷全球市場報告

Respiratory Syncytial Virus (RSV) Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

呼吸道融合細胞病毒(RSV) 診斷市場規模預計在未來幾年將快速成長。到 2029 年，這一數字將成長至 16.8 億美元，複合年成長率為 10.7%。預測期內推動成長的關鍵因素包括呼吸道融合細胞病毒(RSV)感染疾病盛行率上升、對 RSV 診斷的認知提高、醫療保健基礎設施擴大、全球醫療保健支出增加以及人口老化。主要趨勢包括分子診斷技術的進步、診斷設備的創新、快速診斷測試 (RDT) 的採用、公司診斷測試組合的擴展以及基因和蛋白質組診斷的發展。

預計呼吸系統疾病盛行率的上升將推動對呼吸道融合細胞病毒(RSV) 診斷的需求。由於空氣污染、吸菸、氣候變遷、都市化和慢性病盛行率上升等因素，氣喘、慢性阻塞性肺病(COPD)、肺炎和呼吸道感染疾病等呼吸道疾病變得越來越普遍。 RSV 診斷在準確及時地識別感染，進行適當的治療、管理和預防嚴重併發症方面發揮關鍵作用。例如，2024 年 11 月，澳洲健康與福利研究所報告稱，預計 2022 年澳洲將有 280 萬人（佔總人口的 11%）患有氣喘。 2023 年，氣喘將佔總疾病負擔的 2.5%，佔總呼吸系統疾病負擔的 35%，2022 年將有 467 人死於氣喘。因此，呼吸系統疾病盛行率的上升正在推動 RSV 診斷市場的成長。

RSV 診斷市場的主要企業正專注於創新的多病毒診斷測試，以提高效率和準確性。多重病毒診斷測試可以從單一患者樣本同時檢測多種呼吸道病毒，例如呼吸道合胞病毒、流感和 COVID-19。例如，2023 年 1 月，美國臨床檢測公司 Sonora Quest Laboratories 宣布了一項新的分子診斷檢測，可從單一檢體中檢測 COVID-19、RSV 和流感。結合這些測試可以簡化流程，減少對多個樣本的需求，並實現更快、更全面的診斷。這種方法將使醫療保健提供者能夠快速做出治療決策並防止這些病毒的傳播。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 - 市場 - 宏觀經濟情境 宏觀經濟情境包括利率、通膨、地緣政治以及感染疾病和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球呼吸道融合細胞病毒（RSV）診斷PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球呼吸道融合細胞病毒（RSV）診斷市場：成長率分析
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場表現：規模與成長，2019-2024 年
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 全球呼吸道融合細胞病毒（RSV）診斷總目標市場（TAM）

第6章市場區隔

  • 全球呼吸道融合細胞病毒(RSV) 診斷市場（依產品類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 套件和檢測試劑
  • 裝置
  • 試劑
  • 其他產品類型
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場（依技術、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 分子診斷
  • 免疫檢測
  • 快速抗原檢測
  • 其他技術
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場（依樣本類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 鼻拭子
  • 咽拭子檢測
  • 支氣管肺泡清洗
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年及 2034 年
  • 醫院
  • 診斷實驗室
  • 居家照護環境
  • 其他最終用戶
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場細分（套件和檢測類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 快速抗原檢測套件
  • 基於PCR的檢測
  • 血清學檢測
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場，按儀器類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • PCR分析儀
  • 免疫檢測分析儀
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場，按試劑類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • PCR試劑
  • 抗體試劑
  • 酵素試劑
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場，按其他產品類型細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 採樣裝置
  • 交通媒體

第7章 區域和國家分析

  • 全球呼吸道融合細胞病毒(RSV) 診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 呼吸道融合細胞病毒（RSV）診斷市場：競爭格局
  • 呼吸道融合細胞病毒（RSV）診斷市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Becton, Dickinson, and Company
  • Quest Diagnostics Incorporated
  • Hologic Inc.
  • BIOMERIEUX SA
  • QuidelOrtho Corporation
  • Bio-Rad Laboratories Inc.
  • DiaSorin SpA
  • Acon Laboratories Inc.
  • Cepheid Inc.
  • Meridian Bioscience Inc.
  • Seegene Inc.
  • LumiraDx Ltd.
  • Sekisui Diagnostics Ltd.
  • Boditech Med Inc.
  • Trinity Biotech plc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年呼吸道融合細胞病毒（RSV）診斷市場：提供新機會的國家
  • 2029年呼吸道融合細胞病毒（RSV）診斷市場：細分市場帶來新機會
  • 呼吸道融合細胞病毒(RSV) 診斷市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r34139

Respiratory syncytial virus (RSV) diagnostics encompass the tests and methods used to detect RSV in patients, typically through respiratory samples such as nasal or throat swabs. These diagnostics are essential for identifying RSV infections, which can cause respiratory illnesses in infants, young children, and the elderly, aiding in appropriate treatment and disease management.

The primary types of RSV diagnostic products include kits and assays, instruments, reagents, and others. Kits and assays are pre-packaged sets containing reagents, materials, and instructions for conducting specific diagnostic tests. Various technologies are used for RSV detection, including molecular diagnostics, immunoassays, and rapid antigen detection tests. Sample types include nasal swabs, throat swabs, and bronchoalveolar lavage. These diagnostics are utilized in hospitals, diagnostic laboratories, home care settings, and other healthcare environments.

The respiratory syncytial virus (RSV) diagnostics market research report is one of a series of new reports from The Business Research Company that provides respiratory syncytial virus (RSV) diagnostics market statistics, including respiratory syncytial virus (RSV) diagnostics industry global market size, regional shares, competitors with a respiratory syncytial virus (RSV) diagnostics market share, detailed respiratory syncytial virus (RSV) diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory syncytial virus (RSV) diagnostics industry. This respiratory syncytial virus (RSV) diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory syncytial virus (RSV) diagnostics market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth during the historic period was driven by the increasing adoption of point-of-care diagnostics, government initiatives to enhance RSV diagnostics, the rising incidence of respiratory diseases in children, the growth of hospital-acquired infections, and the growing demand for non-invasive diagnostic methods.

The respiratory syncytial virus (RSV) diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.68 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The projected growth during the forecast period is driven by the increasing prevalence of respiratory syncytial virus (RSV) infections, rising awareness of RSV diagnostics, expanding healthcare infrastructure, growing global healthcare spending, and the aging population. Key trends include advancements in molecular diagnostic technologies, technological innovations in diagnostic devices, the adoption of rapid diagnostic tests (RDTs), the expansion of diagnostic test portfolios by companies, and progress in genetic and proteomic diagnostics.

The increasing prevalence of respiratory diseases is expected to drive the demand for respiratory syncytial virus (RSV) diagnostics. Respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and respiratory infections, are becoming more widespread due to factors such as air pollution, smoking, climate change, urbanization, and the rising incidence of chronic conditions. RSV diagnostics play a crucial role in identifying infections accurately and in a timely manner, enabling appropriate treatment, management, and prevention of severe complications, particularly in vulnerable populations. For instance, in November 2024, the Australian Institute of Health and Welfare reported that an estimated 2.8 million people (11% of the population) in Australia were living with asthma in 2022. Asthma accounted for 2.5% of the total disease burden and 35% of the burden from all respiratory conditions in 2023, with 467 asthma-related deaths in 2022. Therefore, the rising prevalence of respiratory diseases is fueling growth in the RSV diagnostics market.

Leading companies in the RSV diagnostics market are focusing on innovative multi-virus diagnostic testing to enhance efficiency and accuracy. Multi-virus diagnostic testing enables the simultaneous detection of multiple respiratory viruses, such as RSV, influenza, and COVID-19, from a single patient sample. For example, in January 2023, Sonora Quest Laboratories, a US-based clinical laboratory testing company, introduced a new molecular diagnostic test that detects COVID-19, RSV, and influenza using a single sample. By combining these tests, the process is streamlined, reducing the need for multiple samples and enabling faster, more comprehensive diagnoses. This approach allows healthcare providers to make quicker treatment decisions and helps prevent the spread of these viruses.

In November 2023, Medix Biochemica, a Finland-based biotechnology company, acquired ViroStat LLC for an undisclosed amount. This acquisition expands Medix Biochemica's infectious disease diagnostic portfolio by integrating ViroStat's expertise in monoclonal antibodies and antigen detection kits for RSV testing. ViroStat LLC, a US-based company, specializes in developing diagnostic solutions for various infectious diseases, including RSV, further strengthening Medix Biochemica's position in the RSV diagnostics market.

Major players in the respiratory syncytial virus (RSV) diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Merck KGaA, Becton, Dickinson, and Company, Quest Diagnostics Incorporated, Hologic Inc., BIOMERIEUX SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Acon Laboratories Inc., Cepheid Inc., Meridian Bioscience Inc., Seegene Inc., LumiraDx Ltd., Sekisui Diagnostics Ltd., Boditech Med Inc., Trinity Biotech plc, R-Biopharm AG, GeneTex Inc., Creative Diagnostics, Certest Biotec S.L., Clarity Diagnostics LLC, Genes 2Me LLP, Coris BioConcept S.A.

North America was the largest region in the respiratory syncytial virus (RSV) diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory syncytial virus (RSV) diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Respiratory Syncytial Virus (RSV) Diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory syncytial virus (RSV) diagnostics market consists of revenues earned by entities by providing services such as diagnostic consultation, research and development support, training and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The respiratory syncytial virus (RSV) diagnostics market also includes sales of immunofluorescence test kits, multiplex panels, sample collection devices and automated testing instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Syncytial Virus (RSV) Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory syncytial virus (rsv) diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory syncytial virus (rsv) diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory syncytial virus (rsv) diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Kits And Assays; Instruments; Reagents; Other Product Types
  • 2) By Technology: Molecular Diagnostics; Immunoassays; Rapid Antigen Detection Tests; Other Technologies
  • 3) By Sample Type: Nasal Swabs; Throat Swabs; Bronchoalveolar Lavage
  • 4) By End User: Hospitals; Diagnostic Laboratories; Home Care Settings; Other End Users
  • Subsegments:
  • 1) By Kits And Assays: Rapid Antigen Detection Kits; PCR-based Assays; Serological Assays
  • 2) By Instruments: PCR Analyzers; Immunoassay Analyzers
  • 3) By Reagents: PCR Reagents; Antibody Reagents; Enzyme Reagents
  • 4) By Other Product Types: Sample Collection Devices; Transport Media
  • Companies Mentioned:F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Merck KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Syncytial Virus (RSV) Diagnostics Market Characteristics

3. Respiratory Syncytial Virus (RSV) Diagnostics Market Trends And Strategies

4. Respiratory Syncytial Virus (RSV) Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Respiratory Syncytial Virus (RSV) Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Respiratory Syncytial Virus (RSV) Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Growth Rate Analysis
  • 5.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Respiratory Syncytial Virus (RSV) Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Respiratory Syncytial Virus (RSV) Diagnostics Total Addressable Market (TAM)

6. Respiratory Syncytial Virus (RSV) Diagnostics Market Segmentation

  • 6.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits And Assays
  • Instruments
  • Reagents
  • Other Product Types
  • 6.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Immunoassays
  • Rapid Antigen Detection Tests
  • Other Technologies
  • 6.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Swabs
  • Throat Swabs
  • Bronchoalveolar Lavage
  • 6.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Home Care Settings
  • Other End Users
  • 6.5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Kits And Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Antigen Detection Kits
  • PCR-based Assays
  • Serological Assays
  • 6.6. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Analyzers
  • Immunoassay Analyzers
  • 6.7. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Reagents
  • Antibody Reagents
  • Enzyme Reagents
  • 6.8. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sample Collection Devices
  • Transport Media

7. Respiratory Syncytial Virus (RSV) Diagnostics Market Regional And Country Analysis

  • 7.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 8.1. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 9.1. China Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 9.2. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 10.1. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 11.1. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 11.2. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 12.1. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 13.1. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 14.1. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 14.2. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 15.1. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 15.2. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 16.1. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 17.1. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 18.1. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 19.1. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 20.1. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 21.1. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 21.2. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 22.1. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 23.1. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 23.2. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 24.1. USA Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 24.2. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 25.1. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 25.2. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 26.1. South America Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 26.2. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 27.1. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 28.1. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 28.2. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 29.1. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 29.2. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Landscape
  • 30.2. Respiratory Syncytial Virus (RSV) Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Syncytial Virus (RSV) Diagnostics Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson, and Company
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Hologic Inc.
  • 31.4. BIOMERIEUX SA
  • 31.5. QuidelOrtho Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. DiaSorin S.p.A.
  • 31.8. Acon Laboratories Inc.
  • 31.9. Cepheid Inc.
  • 31.10. Meridian Bioscience Inc.
  • 31.11. Seegene Inc.
  • 31.12. LumiraDx Ltd.
  • 31.13. Sekisui Diagnostics Ltd.
  • 31.14. Boditech Med Inc.
  • 31.15. Trinity Biotech plc

32. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Syncytial Virus (RSV) Diagnostics Market

34. Recent Developments In The Respiratory Syncytial Virus (RSV) Diagnostics Market

35. Respiratory Syncytial Virus (RSV) Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer